s-nitroso-n-acetylpenicillamine has been researched along with Hyperplasia in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahanchi, SS; Hrabie, JA; Jiang, Q; Kapadia, MR; Keefer, LK; Kibbe, MR; Martinez, J; Pearce, CG; Saavedra, JE; Tsihlis, ND; Varu, VN | 1 |
| Flannery, WD; Jiang, Q; Kapadia, MR; Kibbe, MR; Oustwani, CS; Tsihlis, ND; Vavra, AK | 1 |
2 other study(ies) available for s-nitroso-n-acetylpenicillamine and Hyperplasia
| Article | Year |
|---|---|
Heightened efficacy of nitric oxide-based therapies in type II diabetes mellitus and metabolic syndrome.
Topics: Animals; Aorta, Abdominal; Apoptosis; Carotid Artery Injuries; Cell Cycle; Cell Proliferation; Cells, Cultured; Diabetes Mellitus, Type 2; Disease Models, Animal; DNA Replication; Dose-Response Relationship, Drug; Hyperplasia; Male; Metabolic Syndrome; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Nitric Oxide; Nitric Oxide Donors; Proline; Rats; Rats, Zucker; Reactive Oxygen Species; S-Nitroso-N-Acetylpenicillamine; Triazenes; Tyrosine | 2008 |
Nitric oxide may inhibit neointimal hyperplasia by decreasing isopeptidase T levels and activity in the vasculature.
Topics: Animals; Carotid Artery Injuries; Cells, Cultured; Disease Models, Animal; Dithiothreitol; Down-Regulation; Endopeptidases; Glutathione; Humans; Hyperplasia; Male; Mice; Mice, Inbred C57BL; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Neointima; Nitric Oxide; Nitric Oxide Donors; Proteasome Endopeptidase Complex; Rats; Rats, Sprague-Dawley; Recombinant Proteins; S-Nitroso-N-Acetylpenicillamine; Time Factors; Ubiquitination; Vascular System Injuries | 2013 |